Deutsche Bank AG Makes New Investment in Corteva, Inc. $CTVA

Deutsche Bank AG purchased a new stake in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 2,957,501 shares of the company’s stock, valued at approximately $250,471,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Elevation Wealth Partners LLC boosted its stake in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares in the last quarter. Clearstead Trust LLC acquired a new stake in shares of Corteva during the second quarter worth $31,000. JPL Wealth Management LLC acquired a new stake in shares of Corteva during the third quarter worth $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Corteva during the second quarter valued at $33,000. Finally, Westfuller Advisors LLC lifted its holdings in shares of Corteva by 2,764.3% during the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after purchasing an additional 387 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA stock opened at $77.97 on Wednesday. The company has a market capitalization of $52.02 billion, a price-to-earnings ratio of 51.64, a P/E/G ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The stock’s fifty day simple moving average is $81.84 and its 200-day simple moving average is $80.12.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CTVA shares. Jefferies Financial Group lifted their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Oppenheimer upped their price objective on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Barclays raised their target price on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Wells Fargo & Company lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Finally, BNP Paribas Exane boosted their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.